Tagesnachrichten
23. Aug. 2026•1 Min. Lesezeit
Dräger Expands Field Safety Notice for Atlan Anaesthesia Workstations Over Ventilator Failure Risk
Dräger has broadened its Field Safety Notice to include more Atlan anaesthesia workstations after identifying a manufacturing defect that may cause ventilator failure.
8
Tagesnachrichten
23. Aug. 2026•1 Min. Lesezeit
MHRA Alerts Missing Safety Info for Tuzulby Prolonged‑Release Tablets
Neuraxpharm UK Ltd reported missing safety information in the Patient Information Leaflet and Summary of Product Characteristics for certain batches of Tuzulby prolonged‑release 20 mg, 30 mg and 40 mg tablets.
Tagesnachrichten
23. Aug. 2026•1 Min. Lesezeit
MHRA Alerts Manufacturing Issue with Xaggitin XL Prolonged‑Release Tablets
Macarthys Laboratories (Martindale Pharma) reported to the MHRA that several batches of Xaggitin XL prolonged‑release tablets contain incorrect tablet counts, prompting a defect notification.
Tagesnachrichten
23. Aug. 2026•1 Min. Lesezeit
Relonchem Reports Particulate Contamination in Gabapentin Oral Solution Bottles
Relonchem Limited notified the MHRA of particle presence in some Gabapentin Relonchem 50 mg/ml oral solution bottles after a customer complaint.